Data gathered: May 17
Alternative Data for Bioventus
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 29 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 88 | Sign up | Sign up | Sign up |
| Google Trends | 8 | Sign up | Sign up | Sign up |
| Patents | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 622 | Sign up | Sign up | Sign up |
| Instagram Followers | 606 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 380 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,908 | Sign up | Sign up | Sign up |
| Twitter Mentions | 17 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 23,900 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 86 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,196 | Sign up | Sign up | Sign up |
About Bioventus
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body’s natural healing process in the United States and internationally.
| Price | $6.63 |
| Target Price | Sign up |
| Volume | 471,260 |
| Market Cap | $422M |
| Year Range | $2.89 - $6.63 |
| Dividend Yield | 0% |
| Revenue per Employee | $446,200 |
| Industry | Medical Devices |
In the news
Bioventus management to meet with Craig HallumMay 14 - Thefly.com |
|
Bioventus: Poised for Growth Amidst Strategic Refinement and Debt ReductionMay 13 - TipRanks |
|
 |
Bioventus (NYSE:BVS) PT Raised to $8.00 at Canaccord Genuity GroupMay 10 - ETF Daily News |
 |
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call TranscriptMay 8 - Yahoo |
 |
Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...May 7 - Yahoo |
Bioventus price target raised by $1 at Canaccord, here's whyMay 7 - Thefly.com |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 129M | 121M | 88M | -4.6M | -1.7M | 0.070 |
| Q4 '23 | 135M | 130M | 86M | -6.1M | -4.5M | 0.070 |
| Q3 '23 | 118M | 114M | 79M | -7.3M | -4.2M | 0.050 |
| Q2 '23 | 136M | 126M | 89M | -3.7M | -780,000 | 0.140 |
| Q1 '23 | 118M | 207M | 74M | -139M | -137M | -0.260 |
Insider Transactions View All
| CHURCH KATRINA J filed to sell 17,042 shares at $4.8. April 15 '24 |
| D'Adamio Anthony filed to sell 58,242 shares at $4.8. April 15 '24 |
| Singleton Mark Leonard filed to sell 34,665 shares at $4.8. April 15 '24 |
| Singleton Mark Leonard filed to sell 25,665 shares at $5.4. March 25 '24 |
| CHURCH KATRINA J filed to sell 14,067 shares at $5.5. March 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$74.55 0% | 64 |
 |
Edwards LifesciencesEW |
$90.11 0% | 58 |
 |
Intuitive SurgicalISRG |
$396.43 0% | 59 |
 |
MedtronicMDT |
$85.64 0% | 56 |
 |
StrykerSYK |
$334.1 0% | 59 |
Read more about Bioventus (BVS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bioventus?
The Market Cap of Bioventus is $422M.
How Many People Work at Bioventus?
As of our latest update, Bioventus employed approximately 1,160 people worldwide. However, it's important to note that Bioventus' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Bioventus' revenue per employee?
$446,200. To calculate Bioventus' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Bioventus?
Currently, the price of one share of Bioventus stock is $6.63.
How can I analyze the BVS stock price chart for investment decisions?
The BVS stock price chart above provides a comprehensive visual representation of Bioventus' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bioventus shares. Our platform offers an up-to-date BVS stock price chart, along with technical data analysis and alternative data insights.
Does BVS offer dividends to its shareholders?
As of our latest update, Bioventus (BVS) does not offer dividends to its shareholders. Investors interested in Bioventus should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bioventus?
Some of the similar stocks of Bioventus are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.